Anti-PD1 Immunotherapy in Hodgkin's Lymphoma: Why It Works and Future Directions.

CancerWife — Tue, 09 Dec 2014 04:42:38 +0000

There have been remarkable results of anti-PD1 causing remissions in heavily pretreated Hodgkin's Lymphoma patients.

Here we examine why this cancer immunotherapy can change the way Hodgkin's Lymphoma patients are treated in the future.

Hodgkin's Lymphoma is a good target for anti-PD1.

Anti-PD1 Immunotherapy in Lung Cancer: Video and Summary

admin — Sat, 22 Nov 2014 03:36:29 +0000

This is an excellent video explaining immunotherapy in lung cancer, primarily focusing on anti-PD1.

This video was published November 4, 2014 by Global Resource for Advancing Cancer Education (GRACE).

Dr. Jack West (Swedish Cancer Center, Seattle) moderates this discussion with Dr. Julie Brahmer (John Hopkins, Baltimore) and Dr. Ben Creelan (Moffitt Cancer Center, Tampa).

cancerwife - anti-CTLA4

Anti-PD1 Immunotherapy in Hodgkin's Lymphoma: Why It Works and Future Directions.

Anti-PD1 Immunotherapy in Lung Cancer: Video and Summary